Roadmap Research: Grants in Neurobiology
Grant Title | Grant Type | Principal Investigator |
---|---|---|
Development of a high throughput screening Galanin 3 receptor assay | R21 | Steven J. Brown, Scripps |
A cell-based screen for inhibitors of intracellular Abeta aggregation | R21 | Matthew P. Delisa, Cornell |
Chemical probes for uncovering differential regulators of apoptosis in cells | R03 | Monanish Deshmukh, UNC |
HTS technology for discovery of drugs targeting GPCR oligomers | R21 | Pyare L. Khanna, DiscoveRx Corporation |
A cell-based screen for small molecule binders of mutant huntingtin messenger RNA | R21 | Robert E. Hughes, Buck Institute for Age Research |
Inhibitor screens for five MAPK kinase kinases important in human disease | R21 | Gary L. Johnson, UNC |
Assay development to identifiy palmitoylation inhibitors of neuronal proteins | R21 | Maurine E. Linder, Washington U |
Multiplexed flow cytometry screens for RGS inhibitors | R21 | Richard R. Neubig, University of Michigan |
High-throughput screening assay development for axonopathic neurodegeration | R21 | Norbert Perrimon, Harvard |
Assay development relating to the HTS of the neuropeptide Y-Y2 receptor | R21 | Claes Wahlestedt, Scripps |
Discovery of novel allosteric modulators of the M1 muscarinic receptor | XO1 | P. Jeffrey Conn, Vanderbilt |
Ligands for premortem diagnosis and treatment of Alzheimer’s disease | XO1 | Jeff A. Kuret, Ohio State |
Discovery of novel allosteric agonist of the M4 muscarinic receptor | XO1 | Colleen M. Niswender, Vanderbilt |
EphA4 receptor antagonists for nervous system repair | XO1 | Elena B. Pasquale, Burnham Institute |
Allosteric modulators of D1 receptors | XO1 | Val J. Watts, Purdue |